Abstract:The adaptive immune response is initiated in lymph nodes by contact between antigen-bearing dendritic cells (DCs) and antigen-specific T cells. A selected number of naïve T cells that recognize a specific antigen may proliferate into expanded clones, differentiate, and acquire an effector phenotype. Despite growing experimental knowledge, certain mechanistic aspects of T cell behavior in lymph nodes remain poorly understood. Computational modeling approaches may help in addressing such gaps. Here we introduce an agent-based model describing T cell movements and their interactions with DCs, leading to activation and expansion of cognate T cell clones, in a two-dimensional representation of the lymph node paracortex. The primary objective was to test the putative role of T cell chemotaxis toward DCs, and quantitatively assess the impact of chemotaxis with respect to T cell priming efficacy. Firstly, we evaluated whether chemotaxis of naïve T cells toward a nearest DC may accelerate the scanning process, by quantifying, through simulations, the number of unique T cell—DC contact events. We demonstrate that, in the presence of naïve T cell-to-DC chemoattraction, a higher total number of contacts occurs, as compared to a T cell random walk scenario. However, the forming swarm of naïve T cells, as these cells get attracted to the neighborhood of a DC, may then physically restrict access of additional T cells to the DC, leading to an actual decrease in the cumulative number of unique contacts between naïve T cells and DCs. Secondly, we investigated the potential role of chemotaxis in maintaining cognate T cell clone expansion. The time course of cognate T cells number in the system was used as a quantitative characteristic of the expansion. Model-based simulations indicate that inclusion of chemotaxis, which is selective for already activated (but not naïve) antigen-specific T cells, may strongly accelerate the time of immune response occurrence, which subsequently increases the overall amplitude of the T cell clone expansion process.

Immunodominance Analysis Through Interactions of CD8+ T Cells and DCs in Lymph Nodes

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

A mathematical model of tumor-immune interactions incorporated with danger model

The Immunologic Dominance of an Epitope Within a Rationally Designed Poly-Epitope Vaccine is Influenced by Multiple Factors.

Universal characterization of epitope immunodominance from a multiscale model of clonal competition in germinal centers

Universal characterization of epitope immunodominance from a multi-scale model of clonal competition in germinal centers

Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes

Germinal centers are permissive to subdominant antibody responses

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Dynamics of stochastic mutation to immunodominance.

Influence of antigen dose and DC number on CD8+ T cell differentiation and proliferation of OT-Ⅰ transgenic mice

Effective assessment of CD4 T cell Immunodominance patterns: impact of antigen processing and HLA restriction

A high-affinity T-helper epitope enhances peptide-pulsed dendritic cell-based vaccine.

Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

Epitope competition weakens specific T cell response to subdominant epitopes

Regulation of T cell expansion by antigen presentation dynamics

The Closely Related CD103+ Dendritic Cells (DCs) and Lymphoid-Resident CD8+ DCs Differ in Their Inflammatory Functions

Model-based assessment of the Role of Uneven Partitioning of Molecular Content on Heterogeneity and Regulation of Differentiation in CD8 T-cell Immune Responses

Role of T Cell-To-Dendritic Cell Chemoattraction in T Cell Priming Initiation in the Lymph Node: An Agent-Based Modeling Study

β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3

The Negative Immunoregulation of Specific CD8+T Cells on Dendritic Cells